CRB3P1

Across TCGA pan-cancer cohorts, CRB3P1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated CRB3P1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher CRB3P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CRB3P1 expression acts as an unfavorable survival marker, although some lineages such as KIRP and LGG show a favorable association.

LIHC, KIRP, and TGCT are the cancer types where CRB3P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	II,III,IV	0.065	0.420	<.001	57	view →
KIRP	DFS	Tertile	II,III,IV	0.830	0.528	.004	51	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	42	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	36	view →
THCA	OS	Quartile	II,III,IV	0.721	0.986	.005	26	view →
LUSC	OS	Tertile	III,IV	0.086	0.664	<.001	24	view →
LGG	OS	Median	All	0.951	0.852	.003	20	view →
SKCM	DFS	Tertile	IV	0.040	0.432	.038	9	view →
GBM	OS	Tertile	All	0.669	0.394	.019	6	view →
SARC	OS	Tertile	All	0.672	0.878	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

CRB3P1–LIHC (DFS)

Open the LIHC breakdown →